| 摘要 |
In accordance with the present invention, fibroproliferative disease or condition characterized by such symptoms as increased levels of <i>c-Jun</i> homodimers, increased heterodimerization of <i>c-Jun</i> with another signaling peptide, increased levels of phosphorylated <i>c-Jun</i>, or increased presence of Jun kinase are treated by administering to the subject an amount of a compound effective to ameliorate one or more of the symptoms of the disease or condition, for example, an antiproliferative or antifibrotic agent. Preferred compounds for administration according to the invention are antisense <i>c-Jun</i> oligonucleotides and compounds that block <i>c-Jun</i> phosphorylation, such as pentoxifylline, or a functional derivative or metabolite thereof. Also provided by the present invention are <i>in vitro</i> tests for identifying whether a test compound is useful for treatment of a subject afflicted with such a disease and kits useful for conducting such assays.
|
